Antibiotic Stakeholders Discuss Ethics Of Testing Limited Population Drugs In Broader Populations

 
• By Michael Cipriano
Antibiotic-resistant-bacteria
The US FDA held a public meeting 12 July to solicit comments on its LPAD draft guidance.

More from Clinical Trials

More from R&D